• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

    JournalISSN 1178-7007eISSN 1178-7007中科院 医学 3区

    年发文量

    研究主题

    论文(3588)

    排序
    1Interplay of Insulin Resistance, Hyperandrogenism, and Obesity in Polycystic Ovary Syndrome: Pathogenesis and Therapeutic Insights
    Bao F, Sun L,Guo W

    Fanfan Bao, Lin Sun, Weiying Guo Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, 130021, People’s Republic of ChinaCorrespondence: Weiying Guo, Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, 130021, People’s Republic of China, Email guowy@jlu.edu.cn; doctorweiyingguo@163.comAbstract: Polycystic ovary syndrome (PCOS) is a complex disorder of ovarian dysfunction primarily driven by a self-perpetuating pathophysiological cycle. This network centrally involves the interplay of insulin resistance (IR), hyperandrogenism, and obesity. IR stimulates ovarian and adrenal androgen production and can promote increased food intake. The resulting hyperandrogenemia, in turn, exacerbates insulin resistance and contributes to obesity. Furthermore, obesity worsens both IR and hormonal dysregulation through the release of inflammatory cytokines and adipokines, thereby reinforcing the entire cycle. This narrative review aims to critically examine the core pathological interplay between IR, hyperandrogenism, and obesity in PCOS. Building on this foundation, the review systematically explores the rationale and emerging evidence for novel therapeutic strategies that target these key components, moving beyond the established framework of current treatments. Lifestyle interventions, including dietary modification and physical activity, remain the cornerstone of PCOS management, particularly for overweight and obese patients. Current PCOS management primarily relies on oral contraceptives for symptomatic control of hyperandrogenism. Insulin-sensitizing agents form the other pillar of therapy. While metformin is widely used, newer classes of antidiabetic drug—including Dipeptidyl peptidase 4 inhibitors, sodium-glucose co-transporter protein 2 inhibitors, and glucagon-like peptide-1 receptor agonists—have demonstrated potential benefits that extend beyond glycemic control, offering improvements in weight, insulin sensitivity, and androgen levels. The discussion also extends to future perspectives, evaluating investigational approaches such as stem cell therapy and aldo-keto reductase 3 inhibitors, which, though not yet part of clinical practice, may represent future targeted treatment avenues. The management of PCOS is evolving from a symptomatic approach towards a more pathophysiologically-targeted and personalized strategy. A deep understanding of the IR-hyperandrogenism-obesity cycle is crucial for developing and implementing these novel therapies, which hold promise for improving long-term reproductive, metabolic, and cardiovascular outcomes for patients with PCOS. Future research should focus on validating these emerging treatments through robust clinical trials and defining their place within individualized treatment algorithms.Keywords: obesity, hyperandrogenism, insulin resistance, PCOS, therapy

    2026
    引用
    AI阅读
    加入学术空间
    2Effects of Non-Weight-Bearing Exercise on Wound Healing and Peripheral Perfusion in Patients with Diabetic Foot Ulcers: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Yajie Su, Yao Zhang, Jing Lv
    2026
    引用
    AI阅读
    加入学术空间
    3Medial Arterial Calcification in Diabetic Foot Disease: A Narrative Review of Mechanisms, Perfusion Assessment, and Implications for Pre-Revascularization Evaluation
    Jiaxin Lei, Mingze Guan
    2026
    引用
    AI阅读
    加入学术空间
    4Prevalence and Factors Associated with Biochemical Thyroid Dysfunction among Adults with Type 2 Diabetes at a Vietnamese Tertiary Hospital: A Cross-Sectional Study
    Hung Cao Dinh, Huy Thanh Tran, Si Luc Nguyen,Loc Phuc Tran, Khanh Kim Dao, Trung The Tran
    2026
    引用
    AI阅读
    加入学术空间
    5SMC5/6-Related Primordial Dwarfism and Associated Metabolic Complications: A Review of Genome Instability and Adipose Tissue Dysfunction
    Yue Zhao, Qian Yang, Shiduo Sun, Xinyang Lv,Xinyi Wei,Geli Liu, Ming Liu,Lihong Jiang
    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 3588 篇论文

    高被引作者

    作者引用发文
    K Nilsson30271
    Christer Sundström30271
    Al-Goblan Abdullah S9531
    Al-Alfi Mohammed A9531
    Khan Muhammad Z9531
    Giulio Marchesini Reggiani6325
    W Kopp5822
    Yohannes Tsegyie5301
    Riccardo Dalle Grave5174
    Simona Calugi5174

    高产作者

    作者引用发文
    Shuchun Chen27429
    Ligang Zhou46126
    Song Wen45925
    Guangyao Song14115
    Huijuan Ma22113
    Hequn Zou33413
    Zelin Li11513
    Xinlu Yuan26311
    Xiaoyu Pan12811
    LuPing Ren9511

    相关期刊

    Journal of Diabetes and its Complications
    Diabetes Research and Clinical Practice
    BMC endocrine disorders
    Lipids in health and disease
    Diabetology & metabolic syndrome
    World journal of diabetes
    Journal of diabetes investigation
    Journal of Diabetes & Metabolic Disorders
    Journal of diabetes research
    Current Diabetes Reviews